StockNews.com Initiates Coverage on Fresenius Medical Care (NYSE:FMS)

Stock analysts at StockNews.com initiated coverage on shares of Fresenius Medical Care (NYSE:FMS) in a research report issued on Thursday. The brokerage set a “strong-buy” rating on the stock.

FMS has been the subject of several other research reports. Truist Financial upped their price target on Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Berenberg Bank began coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 price target for the company.

Fresenius Medical Care Stock Up 1.7 %

NYSE FMS traded up $0.37 on Thursday, reaching $22.48. The stock had a trading volume of 146,767 shares, compared to its average volume of 361,283. The business has a 50 day moving average price of $20.93 and a 200 day moving average price of $20.32. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. Fresenius Medical Care has a 1 year low of $17.93 and a 1 year high of $22.76. The company has a market capitalization of $13.19 billion, a price-to-earnings ratio of 18.58, a P/E/G ratio of 1.03 and a beta of 0.91.

Institutional Trading of Fresenius Medical Care

Several hedge funds have recently added to or reduced their stakes in the business. Allworth Financial LP boosted its stake in Fresenius Medical Care by 53.1% during the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock valued at $36,000 after purchasing an additional 581 shares during the period. Mercer Global Advisors Inc. ADV boosted its stake in Fresenius Medical Care by 4.5% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 14,581 shares of the company’s stock valued at $278,000 after purchasing an additional 624 shares during the period. Signaturefd LLC boosted its stake in Fresenius Medical Care by 8.4% during the 2nd quarter. Signaturefd LLC now owns 8,713 shares of the company’s stock valued at $166,000 after purchasing an additional 672 shares during the period. MML Investors Services LLC boosted its stake in Fresenius Medical Care by 5.3% during the 3rd quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock valued at $320,000 after purchasing an additional 753 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in Fresenius Medical Care by 2.5% during the 2nd quarter. Ritholtz Wealth Management now owns 36,901 shares of the company’s stock valued at $704,000 after purchasing an additional 895 shares during the period. Institutional investors own 8.25% of the company’s stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.